✦ LIBER ✦

930 ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER ATTENUATES THE PROGRESSION OF NONALCOHOLIC STEATOHEPATITIS (NASH)

✍ Scribed by A. Hirose; M. Ono; T. Saibara; Y. Nozaki; M. Takahashi; S. Iwasaki; J.A. Oben; S. Onishi

Book ID: 117376857
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 71 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60932-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The angiotensin II type 1 receptor block

The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy

✍ Tetsufumi Yamamoto; Masataka Sata; Daiju Fukuda; Shinichi Takamoto 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 486 KB

Losartan, an angiotensin-II type 1 recep

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

✍ Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Tadashi Namisaki; Mitsuteru 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 379 KB

Targeting the renin-angiotensin system:

Targeting the renin-angiotensin system: Potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis

✍ Silvia Sookoian; Carlos J. Pirola 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong

Angiotensin II Type 1 Receptor Blocker A

Angiotensin II Type 1 Receptor Blocker Attenuates the Exacerbation of Left Ventricular Remodeling and Failure in Diabetes-associated Myocardial Infarction

✍ Hidenori Matsusaka; Masaki Ikeuchi; Shouji Matsushima; Tomomi Ide; Toru Kubota; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Association between angiotensin II type

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease

✍ Masato Yoneda; Kikuko Hotta; Yuichi Nozaki; Hiroki Endo; Takashi Uchiyama; Hiron 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Mechanism of Angiotensin II Type 1 Recep

Mechanism of Angiotensin II Type 1 Receptor Blocker Action in the Regression of Left Ventricular Hypertrophy

✍ Sverre E. Kjeldsen; Arne Strand; Stevo Julius; Peter M. Okin 📂 Article 📅 2006 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 167 KB